Novo Nordisk A/S (ADR) (NYSE: NVO) presented data at the American Diabetes Association on Monday and trusted the doctors in attendance to not share the confidential and market-moving data they just saw.
As if that would actually happen in the...
The Dow fell 0.52 percent to 17,639.76, while the NASDAQ composite index declined 0.42 percent to 4,828.30. The broader Standard & Poor's 500 index dropped 0.47 percent to 2,069.30.
The worst performing industries in the market today...
WASHINGTON (dpa-AFX) - Novo Nordisk Canada Inc. announced that Victoza
(liraglutide) significantly reduced the risk of the composite primary endpoint
of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Novo nordisk a/s (nvo):